News
BrainChild Bio’s B7-H3 CAR T-cell therapy for incurable paediatric brain tumours receives US FDA RMAT designation: Seattle Friday, May 16, 2025, 17:00 Hrs [IST] BrainChild Bio, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback